We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-14.08%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.9B
AUM Growth
-$2.54B
Cap. Flow
-$55.2M
Cap. Flow %
-0.43%
Top 10 Hldgs %
24%
Holding
2,963
New
235
Increased
680
Reduced
1,092
Closed
109

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Healthcare 13.41%
3 Financials 11.93%
4 Consumer Discretionary 10.01%
5 Industrials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIBB
2051
DELISTED
Hibbett, Inc. Common Stock
HIBB
$284K ﹤0.01%
6,500
TBI
2052
Trueblue
TBI
$309M
$284K ﹤0.01%
15,861
-2,079
-12% -$48.8K
CRGE
2053
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$283K ﹤0.01%
+59,398
New +$307K
CLAR icon
2054
Clarus
CLAR
$145M
$283K ﹤0.01%
14,919
QNST icon
2055
QuinStreet
QNST
$1.19B
$283K ﹤0.01%
28,152
DSEY
2056
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$283K ﹤0.01%
42,906
+38,718
+924% +$326K
EBF icon
2057
Ennis
EBF
$559M
$283K ﹤0.01%
13,965
MOD icon
2058
Modine Manufacturing
MOD
$10.8B
$282K ﹤0.01%
26,751
+3,858
+17% +$36.5K
FC icon
2059
Franklin Covey
FC
$227M
$281K ﹤0.01%
6,081
BTRS
2060
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$280K ﹤0.01%
56,276
CSV icon
2061
Carriage Services
CSV
$555M
$280K ﹤0.01%
7,052
-1,639
-19% -$70.7K
SRDX
2062
DELISTED
Surmodics
SRDX
$279K ﹤0.01%
7,505
UBA
2063
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$279K ﹤0.01%
17,230
BRY
2064
DELISTED
Berry Corp
BRY
$279K ﹤0.01%
36,618
OSG
2065
Octave Specialty Group
OSG
$212M
$279K ﹤0.01%
24,566
MVIS icon
2066
Microvision
MVIS
$89.7M
$279K ﹤0.01%
4,840
-401
-8% -$21.5K
PNT
2067
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$279K ﹤0.01%
+40,935
New +$313K
DAWN
2068
DELISTED
Day One Biopharmaceuticals
DAWN
$279K ﹤0.01%
15,573
CRSR icon
2069
Corsair Gaming
CRSR
$1.45B
$278K ﹤0.01%
21,183
+5,794
+38% +$94.5K
PMVP icon
2070
PMV Pharmaceuticals
PMVP
$65.1M
$278K ﹤0.01%
19,508
+2,690
+16% +$39.1K
OSCR icon
2071
Oscar Health
OSCR
$9.5B
$278K ﹤0.01%
+65,383
New +$416K
ZGN icon
2072
Zegna
ZGN
$3.73B
$278K ﹤0.01%
+26,329
New +$270K
RDUS
2073
DELISTED
Radius Health, Inc.
RDUS
$278K ﹤0.01%
26,780
+3,546
+15% +$26.4K
AVIR icon
2074
Atea Pharmaceuticals
AVIR
$406M
$277K ﹤0.01%
39,066
IIIV icon
2075
i3 Verticals
IIIV
$325M
$277K ﹤0.01%
11,069

Similar funds

MetLife Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, MetLife Investment Management held 2,963 positions worth $12.9B, down 16% from $15.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

MetLife Investment Management's Q2 2022 filing shows 235 new, 680 increased, 1,092 reduced and 109 closed positions. Its largest new stake was Airbnb: 23,229 shares worth $2.07M. The largest sale was Apple, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2022 buy was Airbnb: 23,229 shares worth $2.07M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $119M increase.
  • MetLife Investment Management's biggest Q2 2022 reduction was Apple, cutting an estimated $21.3M.
  • MetLife Investment Management fully exited Cerner Corp in Q2 2022, selling an estimated $7.49M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12.9B portfolio in Q2 2022.
  • MetLife Investment Management opened 235 new positions and closed 109 in Q2 2022.
  • MetLife Investment Management's portfolio value fell 16% quarter-over-quarter to $12.9B.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.